Filtrer vos résultats
- 3
- 1
- 4
- 4
- 3
- 1
- 4
- 3
- 3
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational studyInfection, 2021, 49 (5), pp.889-905. ⟨10.1007/s15010-021-01599-5⟩
Article dans une revue
hal-03273644v1
|
||
|
Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumoniaAmerican Journal of Physiology - Lung Cellular and Molecular Physiology, 2021, 321 (5), pp.L847 - L858. ⟨10.1152/ajplung.00105.2021⟩
Article dans une revue
hal-03416731v1
|
||
Tolerance and efficacy of antifibrotic treatments in IPF patients carriying telomere related gene mutationsEuropean Respiratory Journal, 2019, 54 (63), ⟨10.1183/13993003.congress-2019.OA2140⟩
Article dans une revue
hal-03591325v1
|
|||
|
Safety and efficacy of pirfenidone and nintedanib in patients with Idiopathic Pulmonary Fibrosis and carrying a telomere related gene mutationEuropean Respiratory Journal, 2021, 57 (2), pp.2003198. ⟨10.1183/13993003.03198-2020⟩
Article dans une revue
hal-03094894v1
|